Prothena CEO Dale Schenck Dies From Pancreatic Cancer

Prothena CEO Dale Schenk, the scientist behind innovative medicines that included bapineuzumab and Tysabri, died from pancreatic cancer on Sept. 30 – less than two years after he revealed his diagnosis.

Prothena Corp. PLC Co-Founder, President and CEO Dale Schenk, a protein immunotherapy pioneer, died on Sept. 30 from pancreatic cancer that he revealed publicly less than two years ago.

Schenk’s death closely followed Prothena’s Sept. 26 announcement that its CEO would take a medical leave of absence to focus...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip